<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39076856</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2153-8174</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Reviews in cardiovascular medicine</Title><ISOAbbreviation>Rev Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular Disease in Post-Acute COVID-19 Syndrome: A Comprehensive Review of Pathophysiology and Diagnosis Approach.</ArticleTitle><Pagination><StartPage>28</StartPage><MedlinePgn>28</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">28</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.31083/j.rcm2401028</ELocationID><Abstract><AbstractText>Long COVID or post-acute Coronavirus disease 2019 (COVID-19), a malady defined by the persistence of COVID-19 symptoms for weeks or even months, is expected to affect the lives of millions of individuals worldwide significantly. Cardiopulmonary symptoms such as chest discomfort, shortness of breath, fatigue, and autonomic manifestations such as postural orthostatic tachycardia syndrome, and arrhythmias are prevalent and widely recognized. A variety of cardiovascular problems, including myocardial inflammation, myocardial infarction, ventricular dysfunction, and endothelial dysfunction, have been described in individuals following the initial acute phase. With over 10,000 published publications on COVID-19 and the cardiovascular system, presenting an unbiased thorough analysis of how SARS-CoV-2 affects the system is essentially challenging. This review will provide an overview of frequent cardiovascular manifestations, emphasizing consequences, proposed pathophysiology, and clinical diagnostic manifestation strategy.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 The Author(s). Published by IMR Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kusumawardhani</LastName><ForeName>Nuraini Yasmin</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putra</LastName><ForeName>Iwan Cahyo Santosa</ForeName><Initials>ICS</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamarullah</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Emergency Department, R. Syamsudin SH Regional Public Hospital, Sukabumi, 43341 West Java, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afrianti</LastName><ForeName>Rien</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pramudyo</LastName><ForeName>Miftah</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prameswari</LastName><ForeName>Hawani Sasmaya</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achmad</LastName><ForeName>Chaerul</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiksnadi</LastName><ForeName>Badai Bhatara</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akbar</LastName><ForeName>Mohammad Rizki</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Padjadjaran, 40132 Bandung, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Rev Cardiovasc Med</MedlineTA><NlmUniqueID>100960007</NlmUniqueID><ISSNLinking>1530-6550</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cardiovascular system</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39076856</ArticleId><ArticleId IdType="pmc">PMC11270463</ArticleId><ArticleId IdType="doi">10.31083/j.rcm2401028</ArticleId><ArticleId IdType="pii">S1530-6550(22)00841-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nature Medicine . 2020;26:1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Ho W, Huang Y, Jin D, Li S, Liu S, et al. SARS-CoV-2 is an appropriate name for the new coronavirus. Lancet . 2020;395:949&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133598</ArticleId><ArticleId IdType="pubmed">32151324</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nature Medicine . 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis. Research Square . 2021 (preprint)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P, Arora U, Kumar A, Wig N. The &#x201c;post-COVID&#x201d; syndrome: How deep is the damage? Journal of Medical Virology . 2021;93:673&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC  Post-COVID Conditions. Centers for Disease Control and Prevention. 2022.  [(Accessed: 5 July 2022)].  Available at:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes &amp; Metabolic Syndrome . 2021;15:145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloch S, Baloch MA, Zheng T, Pei X. The Coronavirus Disease 2019 (COVID-19) Pandemic. The Tohoku Journal of Experimental Medicine . 2020;250:271&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">32321874</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi GA, Sacco O, Mancino E, Cristiani L, Midulla F. Differences and similarities between SARS-CoV and SARS-CoV-2: spike receptor-binding domain recognition and host cell infection with support of cellular serine proteases. Infection . 2020;48:665&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393809</ArticleId><ArticleId IdType="pubmed">32737833</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park Y, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell . 2020;181:281&#x2013;292. e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Astuti I, Ysrafil Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes &amp; Metabolic Syndrome . 2020;14:407&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7165108</ArticleId><ArticleId IdType="pubmed">32335367</ArticleId></ArticleIdList></Reference><Reference><Citation>Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19) 2020.  [(Accessed: 18 April 2020)].  In: StatPearls. Treasure Island (FL): StatPearls Publishing. Available at:  http://www.ncbi.nlm.nih.gov/books/NBK554776/</Citation></Reference><Reference><Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science . 2020;367:1260&#x2013;1263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshdy A, Zaher S, Fayed H, Coghlan JG. COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies. Frontiers in Cardiovascular Medicine . 2021;7:626975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876291</ArticleId><ArticleId IdType="pubmed">33585586</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B, Nazarian S, Muser D, Deo R, Santangeli P, Khanji MY, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm . 2020;17:1463&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Suthahar N, Meijers WC, Sillj&#xe9; HHW, de Boer RA. From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Current Heart Failure Reports . 2017;14:235&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5527069</ArticleId><ArticleId IdType="pubmed">28707261</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet . 2020;395:1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes-Bezerra LM, Filler SG. Endothelial cells, tissue factor and infectious diseases. Brazilian Journal of Medical and Biological Research . 2003;36:987&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">12886452</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Martin S, Shchendrygina A, Hoffmann J, Ka MM, Giokoglu E, et al. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med . 2022;28:2117&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Zhu Y, Wang S, Jia S, Gao Y, Lu Y, et al. SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection. Signal Transduction and Targeted Therapy . 2021;6:368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8512652</ArticleId><ArticleId IdType="pubmed">34645784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: A review. Journal of Infection and Public Health . 2020;13:1619&#x2013;1629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7359800</ArticleId><ArticleId IdType="pubmed">32718895</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a LF. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Frontiers in Immunology . 2020;11:1441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308593</ArticleId><ArticleId IdType="pubmed">32612615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu H, Chan JF, Wang Y, Yuen TT, Chai Y, Hou Y, et al. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19. Clinical Infectious Diseases . 2020;71:1400&#x2013;1409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184390</ArticleId><ArticleId IdType="pubmed">32270184</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu W, Uhl S, Hoagland D, M&#xf8;ller R, et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell . 2020;181:1036&#x2013;1045. e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu B, Fan C, Wang A, Zou Y, Yu Y, He C, et al. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. The Journal of Infection . 2020;81:e51&#x2013;e60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166040</ArticleId><ArticleId IdType="pubmed">32315725</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis. Journal of Intensive Care . 2020;8:36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245646</ArticleId><ArticleId IdType="pubmed">32483488</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Liu Y, Cao L, Wang D, Guo M, Jiang A, et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging Microbes &amp; Infections . 2020;9:761&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7170362</ArticleId><ArticleId IdType="pubmed">32228226</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Diao B, Wang R, Wang G, Wang C, Tan Y, et al.  The Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Directly Decimates Human Spleens and Lymph Nodes. 2020.  [(Accessed: 9 September 2021)].  Available at:  https://www.medrxiv.org/content/10.1101/2020.03.27.20045427v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.27.20045427v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Zhang M, Yang C, Zhang N, Wang X, Yang X, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cellular &amp; Molecular Immunology . 2020;17:541&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7091621</ArticleId><ArticleId IdType="pubmed">32203186</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies. Frontiers in Immunology . 2020;11:1708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7365923</ArticleId><ArticleId IdType="pubmed">32754163</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorham J, Moreau A, Corazza F, Peluso L, Ponthieux F, Talamonti M, et al. Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis. PLoS ONE . 2020;15:e0244628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7774924</ArticleId><ArticleId IdType="pubmed">33382773</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Seminars in Immunopathology . 2017;39:529&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman ML, Panigrahi S, Chen B, Juchnowski S, Sieg SF, Lederman MM, et al. CD8+ T-Cell-Derived Tumor Necrosis Factor Can Induce Tissue Factor Expression on Monocytes. The Journal of Infectious Diseases . 2019;220:73&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548895</ArticleId><ArticleId IdType="pubmed">30698729</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, van der Poll T. Inflammation and coagulation. Critical Care Medicine . 2010;38:S26&#x2013;S34.</Citation><ArticleIdList><ArticleId IdType="pubmed">20083910</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikellis C, Bernardi S, Burns WC. Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease. Current Opinion in Nephrology and Hypertension . 2011;20:62&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">21099686</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A, Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension . 2004;44:264&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">15262905</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends in Pharmacological Sciences . 2008;29:367&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pubmed">18579222</ArticleId></ArticleIdList></Reference><Reference><Citation>Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circulation Research . 2008;102:488&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">18096818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalinina N, Agrotis A, Tararak E, Antropova Y, Kanellakis P, Ilyinskaya O, et al. Cytochrome b558-dependent NAD(P)H oxidase-phox units in smooth muscle and macrophages of atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology . 2002;22:2037&#x2013;2043.</Citation><ArticleIdList><ArticleId IdType="pubmed">12482831</ArticleId></ArticleIdList></Reference><Reference><Citation>Imanishi T, Kobayashi K, Kuroi A, Mochizuki S, Goto M, Yoshida K, et al. Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor. Hypertension . 2006;48:1058&#x2013;1065.</Citation><ArticleIdList><ArticleId IdType="pubmed">17060506</ArticleId></ArticleIdList></Reference><Reference><Citation>Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by angiotensin II. Methods and Findings in Experimental and Clinical Pharmacology . 2000;22:709&#x2013;723.</Citation><ArticleIdList><ArticleId IdType="pubmed">11346891</ArticleId></ArticleIdList></Reference><Reference><Citation>Keim KL, Sigg EB. Activation of central sympathetic neurons by angiotensin II. Life Sciences. Pt. 1: Physiology and Pharmacology . 1971;10:565&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">4325511</ArticleId></ArticleIdList></Reference><Reference><Citation>Reit E. Actions of angiotensin on the adrenal medulla and autonomic ganglia. Federation Proceedings . 1972;31:1338&#x2013;1343.</Citation><ArticleIdList><ArticleId IdType="pubmed">4338895</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns EJ. Role of angiotensin II and the sympathetic nervous system in the control of renal function. Journal of Hypertension . 1989;7:695&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">2677135</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks VL, Reid IA. Interaction between angiotensin II and the baroreceptor reflex in the control of adrenocorticotropic hormone secretion and heart rate in conscious dogs. Circulation Research . 1986;58:816&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">3013462</ArticleId></ArticleIdList></Reference><Reference><Citation>He M, He X, Xie Q, Chen F, He S. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. Thrombosis Research . 2006;117:579&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">15953627</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson PT, Schwieler JH, Wall&#xe9;n NH. Platelet activation during angiotensin II infusion in healthy volunteers. Blood Coagulation &amp; Fibrinolysis . 2000;11:61&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">10691100</ArticleId></ArticleIdList></Reference><Reference><Citation>Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW, Granger DN. Angiotensin II-mediated microvascular thrombosis. Hypertension . 2010;56:1089&#x2013;1095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3023299</ArticleId><ArticleId IdType="pubmed">20975035</ArticleId></ArticleIdList></Reference><Reference><Citation>Thekkumkara TJ, Cookson R, Linas SL. Angiotensin (AT1A) receptor-mediated increases in transcellular sodium transport in proximal tubule cells. The American Journal of Physiology . 1998;274:F897&#x2013;F905.</Citation><ArticleIdList><ArticleId IdType="pubmed">9612327</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera G. Role of angiotensin II receptor subtypes on the regulation of aldosterone secretion in the adrenal glomerulosa zone in the rat. Molecular and Cellular Endocrinology . 1992;90:53&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">1338730</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobe JL, Mecca AP, Mao H, Katovich MJ. Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. American Journal of Physiology. Heart and Circulatory Physiology . 2006;290:H2417&#x2013;H2423.</Citation><ArticleIdList><ArticleId IdType="pubmed">16415071</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AJ, Castro CH, Guatimosim S, Almeida PWM, Gomes ERM, Dias-Peixoto MF, et al. Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart. Therapeutic Advances in Cardiovascular Disease . 2010;4:83&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">20051448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AJ, Shenoy V, Qi Y, Fraga-Silva RA, Santos RAS, Katovich MJ, et al. Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Experimental Physiology . 2011;96:287&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3077555</ArticleId><ArticleId IdType="pubmed">21148624</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu E, Yang S, Xu Z, Li J, Yang W, Li G. Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs. Regulatory Peptides . 2010;162:73&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">20074590</ArticleId></ArticleIdList></Reference><Reference><Citation>Shangguan W, Shi W, Li G, Wang Y, Li J, Wang X. Angiotensin-(1-7) attenuates atrial tachycardia-induced sympathetic nerve remodeling. Journal of the Renin-angiotensin-aldosterone System . 2017;18:1470320317729281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5843893</ArticleId><ArticleId IdType="pubmed">28877652</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y, Shenoy V, Wong F, Li H, Afzal A, Mocco J, et al. Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology. Experimental Physiology . 2011;96:863&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3755594</ArticleId><ArticleId IdType="pubmed">21685447</ArticleId></ArticleIdList></Reference><Reference><Citation>Ea T, Cm F, Pe G. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. 2005.  [(Accessed: 4 September 2021)].  American journal of physiology. Heart and Circulatory Physiology. Available at:  https://pubmed.ncbi.nlm.nih.gov/15951342/</Citation><ArticleIdList><ArticleId IdType="pubmed">15951342</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos RAS, Ferreira AJ, Nadu AP, Braga ANG, de Almeida AP, Campagnole-Santos MJ, et al. Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats. Physiological Genomics . 2004;17:292&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">15039487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, et al. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circulation Research . 2008;103:1319&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pubmed">18845809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation . 2010;122:717&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pubmed">20679547</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria-Silva R, Duarte FV, Santos RAS. Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats. Hypertension . 2005;46:948&#x2013;952.</Citation><ArticleIdList><ArticleId IdType="pubmed">16087780</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa MA, Lopez Verrilli MA, Gomez KA, Nakagawa P, Pe&#xf1;a C, Arranz C, et al. Angiotensin-(1-7) upregulates cardiac nitric oxide synthase in spontaneously hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology . 2010;299:H1205&#x2013;H1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">20675563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Zhao T, Chen Y, Sun Y. Angiotensin 1-7 promotes cardiac angiogenesis following infarction. Current Vascular Pharmacology . 2015;13:37&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">23628010</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovren F, Pan Y, Quan A, Teoh H, Wang G, Shukla PC, et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. American Journal of Physiology. Heart and Circulatory Physiology . 2008;295:H1377&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">18660448</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, et al. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arteriosclerosis, Thrombosis, and Vascular Biology . 2013;33:1978&#x2013;1985.</Citation><ArticleIdList><ArticleId IdType="pubmed">23723368</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga-Silva RA, Pinheiro SVB, Gon&#xe7;alves ACC, Alenina N, Bader M, Santos RAS. The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets. Molecular Medicine . 2008;14:28&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2078558</ArticleId><ArticleId IdType="pubmed">18026570</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, et al. Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension . 2012;59:300&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">22184331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocaranza MP, Lavandero S, Jalil JE, Moya J, Pinto M, Novoa U, et al. Angiotensin-(1-9) regulates cardiac hypertrophy in vivo and in vitro. Journal of Hypertension . 2010;28:1054&#x2013;1064.</Citation><ArticleIdList><ArticleId IdType="pubmed">20411619</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020.  [(Accessed: 24 April 2020)].  Available at:  https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30079-5/abstract.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, et al. Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury. Circulation . 2019;140:1661&#x2013;1678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855329</ArticleId><ArticleId IdType="pubmed">31416350</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RM, Frazier DP, Thompson JW, Haliko S, Li H, Wasserlauf BJ, et al. A unique pathway of cardiac myocyte death caused by hypoxia-acidosis. The Journal of Experimental Biology . 2004;207:3189&#x2013;3200.</Citation><ArticleIdList><ArticleId IdType="pubmed">15299040</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proceedings of the National Academy of Sciences of the United States of America . 2002;99:12825&#x2013;12830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC130544</ArticleId><ArticleId IdType="pubmed">12226479</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas A, Perros F, Tu L, Cohen-Kaminsky S, Montani D, Dorfm&#xfc;ller P, et al. Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay. Circulation . 2014;129:1332&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">24664216</ArticleId></ArticleIdList></Reference><Reference><Citation>Price LC, McAuley DF, Marino PS, Finney SJ, Griffiths MJ, Wort SJ. Pathophysiology of pulmonary hypertension in acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology . 2012;302:L803&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3362157</ArticleId><ArticleId IdType="pubmed">22246001</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Chesler NC. Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulmonary Circulation . 2011;1:212&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3198648</ArticleId><ArticleId IdType="pubmed">22034607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunsch H. Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology. American Journal of Respiratory and Critical Care Medicine . 2020;202:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328308</ArticleId><ArticleId IdType="pubmed">32402207</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;bler MR, Wigger O, Berger D, Bl&#xf6;chlinger S. Basic concepts of heart-lung interactions during mechanical ventilation. Swiss Medical Weekly . 2017;147:w14491.</Citation><ArticleIdList><ArticleId IdType="pubmed">28944931</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt JP, Rhode EA, Kines H. Pericardial and ventricular pressure. Circulation Research . 1960;8:1171&#x2013;1181.</Citation><ArticleIdList><ArticleId IdType="pubmed">13715537</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansdorp B, Hofhuizen C, van Lavieren M, van Swieten H, Lemson J, van Putten MJAM, et al. Mechanical ventilation-induced intrathoracic pressure distribution and heart-lung interactions*. Critical Care Medicine . 2014;42:1983&#x2013;1990.</Citation><ArticleIdList><ArticleId IdType="pubmed">24743042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross PA, Khemani RG, Rubin SS, Bhalla AK, Newth CJL. Elevated positive end-expiratory pressure decreases cardiac index in a rhesus monkey model. Frontiers in Pediatrics . 2014;2:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4253666</ArticleId><ArticleId IdType="pubmed">25520944</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AD, Fowler RA, Burns KEA, Rose L, Pinto RL, Scales DC. Long-Term Outcomes and Health Care Utilization after Prolonged Mechanical Ventilation. Annals of the American Thoracic Society . 2017;14:355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">28033033</ArticleId></ArticleIdList></Reference><Reference><Citation>King CS, Sahjwani D, Brown AW, Feroz S, Cameron P, Osborn E, et al. Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. PLoS One . 2020;15:e0242651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682899</ArticleId><ArticleId IdType="pubmed">33227024</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet . 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;n IP, Mart&#xed; CR, Sota DPDL, &#xc1;lvarez AC, Gimeno MJE, Juana SF, et al. Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission. Journal of Medical Virology . 2022;94:205&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662039</ArticleId><ArticleId IdType="pubmed">34436783</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Guijarro C, Plaza-Canteli S, Hern&#xe1;ndez-Barrera V, Torres-Macho J. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study. Lung . 2021;199:249&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamberini L, Mazzoli CA, Prediletto I, Sintonen H, Scaramuzzo G, Allegri D, et al. Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respiratory Medicine . 2021;189:106665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8531241</ArticleId><ArticleId IdType="pubmed">34717097</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K, et al. Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China. Clinical Infectious Diseases . 2022;74:1953&#x2013;1965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xc1;, Mata-V&#xe1;zquez E, Mart&#xed;n-Toledano M, L&#xf3;pez-Larramona G, Ruiz-Chicote AM, et al. Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge. Journal of Clinical Medicine . 2021;10:2945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestrini V, Birtolo LI, Francone M, Galardo G, Galea N, Severino P, et al. Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up. International Journal of Cardiology . 2021;339:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253670</ArticleId><ArticleId IdType="pubmed">34224766</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez R, Balanz&#xe1;-Mart&#xed;nez V, Luperdi SC, Estrada I, Latorre A, Gonz&#xe1;lez-Jim&#xe9;nez P, et al. Long-term neuropsychiatric outcomes in COVID-19 survivors: A 1-year longitudinal study. Journal of Internal Medicine . 2022;291:247&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662064</ArticleId><ArticleId IdType="pubmed">34569681</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhre PL, Heck SL, Skranes JB, Prebensen C, Jonassen CM, Berge T, et al. Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity. American Heart Journal . 2021;242:61&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363180</ArticleId><ArticleId IdType="pubmed">34400140</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19) JAMA Cardiology . 2020;5:1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, Filippini N, Griffanti L, Alfaro-Almagro F, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine . 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clinical Infectious Diseases . 2022;74:1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. The European Respiratory Journal . 2021;57:2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B, et al. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China. JAMA Network Open . 2021;4:e2127403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Yang C, An X, Xiong Y, Shang Y, He J, et al. Follow-up study on COVID-19 survivors one year after discharge from hospital. International Journal of Infectious Diseases . 2021;112:173&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8434916</ArticleId><ArticleId IdType="pubmed">34520845</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Wong C, Un K, Lau Y, Lee JC, Tam FC, et al. Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS ONE . 2021;16:e0246732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877588</ArticleId><ArticleId IdType="pubmed">33571321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonaglioni A, Lombardo M, Albini A, Noonan DM, Re M, Cassandro R, et al. Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period. Frontiers in Immunology . 2022;13:958418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453812</ArticleId><ArticleId IdType="pubmed">36090992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. The Journal of Clinical Investigation . 1995;95:2409&#x2013;2415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC295872</ArticleId><ArticleId IdType="pubmed">7738205</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappetta S, Sharma AM, Bottino V, Stier C. COVID-19 and the role of chronic inflammation in patients with obesity. International Journal of Obesity . 2020;44:1790&#x2013;1792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224343</ArticleId><ArticleId IdType="pubmed">32409680</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network &#x2014; United States, March&#x2013;June 2020. MMWR Morb Mortal Wkly Rep. 2020.  [(Accessed: 11 September 2021)].  Available at:  https://www.cdc.gov/mmwr/volumes/69/wr/mm6930e1.htm.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman-Edelstein M, Guetta T, Barnea A, Waldman M, Ben-Dor N, Barac YD, et al. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system. Cardiovascular Diabetology . 2021;20:90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078096</ArticleId><ArticleId IdType="pubmed">33906662</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkogkou E, Barnasas G, Vougas K, Trougakos IP. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators. Redox Biology . 2020;36:101615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311357</ArticleId><ArticleId IdType="pubmed">32863223</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroumand AB, Forouhi M, Karimi F, Moghadam AS, Naeini LG, Kokabian P, et al. Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review. Frontiers in Immunology . 2022;13:940357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465310</ArticleId><ArticleId IdType="pubmed">36105809</ArticleId></ArticleIdList></Reference><Reference><Citation>Richette P, Poitou C, Garnero P, Vicaut E, Bouillot J, Lacorte J, et al. Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis. Annals of the Rheumatic Diseases . 2011;70:139&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">20980288</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, Zhou N, Zha W, Lv Y. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutrition, Metabolism, and Cardiovascular Diseases . 2021;31:745&#x2013;755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831720</ArticleId><ArticleId IdType="pubmed">33549450</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao L, Harrison DG. Inflammation in Hypertension. The Canadian Journal of Cardiology . 2020;36:635&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7733126</ArticleId><ArticleId IdType="pubmed">32389337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Arias-Naval&#xf3;n JA, Hern&#xe1;ndez-Barrera V, et al. Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case-control study. Journal of Human Hypertension . 2022;36:582&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren L, Yu S, Xu W, Overton JL, Chiamvimonvat N, Thai PN. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis. Journal of Cardiology . 2021;77:482&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605745</ArticleId><ArticleId IdType="pubmed">33168337</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, Maggi P, Messina V, Iuliano P, Sardu A, Iovinella V, et al. Could Anti-Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID-19 Infection? Data From Centers of Southern Italy. Journal of the American Heart Association . 2020;9:e016948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660768</ArticleId><ArticleId IdType="pubmed">32633594</ArticleId></ArticleIdList></Reference><Reference><Citation>Soegiarto G, Wulandari L, Purnomosari D, Dhia Fahmita K, Ikhwan Gautama H, Tri Hadmoko S, et al. Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2. Vaccine . 2022;40:4046&#x2013;4056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9135674</ArticleId><ArticleId IdType="pubmed">35660034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, et al. Implications of AB0 blood group in hypertensive patients with covid-19. BMC Cardiovascular Disorders . 2020;20:373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427694</ArticleId><ArticleId IdType="pubmed">32799852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes &amp; Metabolic Syndrome . 2020;14:535&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200339</ArticleId><ArticleId IdType="pubmed">32408118</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Cai Z, Zhang J. Hyperglycemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: a meta-analysis. Bioscience Reports . 2021;41:BSR20203584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7876597</ArticleId><ArticleId IdType="pubmed">33480978</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R, Sardu C, D&#x2019;Onofrio N, Prattichizzo F, Scisciola L, Messina V, et al. Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes. Nature Communications . 2022;13:2318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9051134</ArticleId><ArticleId IdType="pubmed">35484164</ArticleId></ArticleIdList></Reference><Reference><Citation>Marfella R, D&#x2019;Onofrio N, Sardu C, Scisciola L, Maggi P, Coppola N, et al. Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study. Diabetes, Obesity &amp; Metabolism . 2022;24:160&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653151</ArticleId><ArticleId IdType="pubmed">34494705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Bae JH, Kwon H, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews. Endocrinology . 2021;17:11&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Canan CH, Gokhale NS, Carruthers B, Lafuse WP, Schlesinger LS, Torrelles JB, et al. Characterization of lung inflammation and its impact on macrophage function in aging. Journal of Leukocyte Biology . 2014;96:473&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4632167</ArticleId><ArticleId IdType="pubmed">24935957</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes E, Fuentes M, Alarc&#xf3;n M, Palomo I. Immune System Dysfunction in the Elderly. Anais Da Academia Brasileira De Ciencias . 2017;89:285&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">28423084</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet . 2021;398:747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanini GG, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M, et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation . 2020;141:2113&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302062</ArticleId><ArticleId IdType="pubmed">32352306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et al.  ST-Segment Elevation in Patients with Covid-19 - A Case Series. The New England Journal of Medicine. 2020.  [(Accessed: 24 November 2022)].  Available at:  https://pubmed.ncbi.nlm.nih.gov/32302081/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182015</ArticleId><ArticleId IdType="pubmed">32302081</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameli M, Pastore MC, Mandoli GE, D&#x2019;Ascenzi F, Focardi M, Biagioni G, et al.  COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications. Frontiers in Cardiovascular Medicine. 2021.  [(Accessed: 30 November 2022)].  Available at:  https://www.frontiersin.org/articles/10.3389/fcvm.2020.593496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.593496</ArticleId><ArticleId IdType="pmc">PMC7876078</ArticleId><ArticleId IdType="pubmed">33585577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassar A, Holmes DR, Rihal CS, Gersh BJ. Chronic coronary artery disease: diagnosis and management. Mayo Clinic Proceedings . 2009;84:1130&#x2013;1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787400</ArticleId><ArticleId IdType="pubmed">19955250</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet JP, Thiele H, Barbato E, Barth&#xe9;l&#xe9;my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) European Heart Journal . 2021;42:1289&#x2013;1367.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) European Heart Journal . 2018;39:119&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Tabas I, Fredman G, Fisher EA. Inflammation and its resolution as determinants of acute coronary syndromes. Circulation Research . 2014;114:1867&#x2013;1879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078767</ArticleId><ArticleId IdType="pubmed">24902971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori M, Cosmi B, Legnani C, Favaretto E, Valdr&#xe9; L, Guazzaloca G, et al. The Wells rule and D-dimer for the diagnosis of isolated distal deep vein thrombosis. Journal of Thrombosis and Haemostasis . 2012;10:2264&#x2013;2269.</Citation><ArticleIdList><ArticleId IdType="pubmed">22906051</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrier A, Desmarais S, Goehring C, de Moerloose P, Morabia A, Unger PF, et al. D-dimer testing for suspected pulmonary embolism in outpatients. American Journal of Respiratory and Critical Care Medicine . 1997;156:492&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">9279229</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G, Harjola V, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) European Heart Journal . 2020;41:543&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504429</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzolai L, Aboyans V, Ageno W, Agnelli G, Alatri A, Bauersachs R, et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. European Heart Journal . 2018;39:4208&#x2013;4218.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329262</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal . 2016;37:2129&#x2013;2200.</Citation><ArticleIdList><ArticleId IdType="pubmed">27206819</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi T, Poh MQW, Fan BE, Li KFC, George J, Tan JYL. Acute hyperhidrosis and postural tachycardia in a COVID-19 patient. Clinical Autonomic Research . 2020;30:571&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511524</ArticleId><ArticleId IdType="pubmed">32970212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K, Jamal S, Kichloo A, Grubb BP. New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection. The Journal of Innovations in Cardiac Rhythm Management . 2020;11:4302&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Sullivan JS, Lyne A, Vaughan CJ. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Reports . 2021;14:e243585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204164</ArticleId><ArticleId IdType="pubmed">34127505</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn D, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clinical Autonomic Research . 2020;30:449&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clinical Medicine . 2021;21:e63&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Guglin M, Nallamshetty L. Myocarditis: diagnosis and treatment. Current Treatment Options in Cardiovascular Medicine . 2012;14:637&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">22927087</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. Journal of the American College of Cardiology . 2009;53:1475&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743893</ArticleId><ArticleId IdType="pubmed">19389557</ArticleId></ArticleIdList></Reference><Reference><Citation>Soongswang J, Durongpisitkul K, Ratanarapee S, Leowattana W, Nana A, Laohaprasitiporn D, et al. Cardiac troponin T: its role in the diagnosis of clinically suspected acute myocarditis and chronic dilated cardiomyopathy in children. Pediatric Cardiology . 2002;23:531&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">12211203</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clinical Microbiology and Infection . 2021;27:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubarik A, Iqbal AM. Holter Monitor. 2021.  [(Accessed: 8 September 2021)].  In: StatPearls. Treasure Island (FL): StatPearls Publishing. Available at:  http://www.ncbi.nlm.nih.gov/books/NBK538203/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>